Market Research Logo

Global Substance Abuse Treatment Market 2017-2021

Global Substance Abuse Treatment Market 2017-2021

About Substance Abuse Treatment

Substance abuse is defined as an illicit use of alcohol, drugs, or cigarettes. They are potentially addictive in nature, difficult to treat, and have a negative impact on body and overall health. The major factors driving the market is the increase in substance usage and the number of associated deaths. It is also identified as a high economic burden. Substance abuse is one of the primary causes of death globally and a major economic burden. Substance abuse, along with addiction is associated with a variety of chronic diseases.

Technavio’s analysts forecast the global substance abuse treatment market to grow at a CAGR of 5.15% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global substance abuse treatment market for 2017-2021. To calculate the market size, the report considers the sales from both generic and branded drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Substance Abuse Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Alkermes
  • Allergan
  • GSK
  • Pfizer
Other prominent vendors
  • Accord Healthcare
  • Amphastar Pharmaceuticals
  • Apotex
  • BioCorRx
  • Cipla
  • Glenmark
  • INSYS Therapeutics
  • LFB Group
  • Lupin
  • Mylan Laboratories
  • Opiant Technologies
  • Sanofi Aventis
  • Sanquin
  • Sterinova
  • Sun Pharma
  • Teva Pharmaceutical
Market driver
  • Multiple facets of treatment
  • For a full, detailed list, view our report
Market challenge
  • High cost of treatment
  • For a full, detailed list, view our report
Market trend
  • Consolidation of rehabilitation centers
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Substance Abuse Treatment Market 2017-2021

Technavio recognizes the following companies as the key players in the global substance abuse treatment market: Alkermes, Allergan, GSK, and Pfizer.

Other Prominent Vendors in the market are: Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Mylan Laboratories, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharma, and Teva Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is consolidation of rehabilitation centers. In the last decade, rehabilitation centers have increasingly adopted inorganic growth strategies. Acquisition of smaller rehabilitation centers by the major rehab centers across the globe have led to a uniformity in treatment patterns, increased capacity of major rehabilitation centers, and presence across various regions. Many of the smaller mental rehabilitation centers have been acquired and have expanded their functionality to include treatment for substance abuse.”

According to the report, one of the major drivers for this market is multiple facets of treatment. Substance abuse is a complex condition and involves every aspect of an individual's functioning, namely family, work/school, and the community. Therefore, a substance abuse treatment involves multiple components, where some are focused on re-establishing an individual as a productive member of the family and community. This approach is to enable an individual to recognize the benefits of a life without substance abuse.

Further, the report states that one of the major factors hindering the growth of this market is high cost of treatment. The cost of treatment for substance abuse is high owing to multiple phases involved. The total cost involves expenses associated with rehabilitation centers and facilities; therapeutics cost’ and cost associated with the physicians, psychologists, councillors, nutritionists, and many other professionals providing secondary therapies. These secondary therapies include patient counselling, health services, and detoxification services, among others.



Companies Mentioned

Alkermes, Allergan, GSK, Pfizer, Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Mylan Laboratories, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharma, and Teva Pharmaceutical.

  • Executive Summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Table Substance abuse: An insight
    • Table Overview: Global substance abuse market
  • An overview of diseases related to substance abuse
    • Table Major diseases associated with substance abuse
  • Market landscape
    • Market overview
      • Table Global substance abuse treatment market: Snapshot
      • Table Global substance abuse treatment market 2016-2021 ($ million)
      • Table Opportunity analysis: Global substance abuse treatment market
    • Five forces analysis
      • Table Source: Technavio
  • Segmentation by type of abuse
    • Table Global substance abuse treatment market by type of abuse 2016
    • Global alcohol abuse treatment market
      • Table Global alcohol abuse treatment market 2016-2021 ($ million)
    • Global nicotine abuse treatment market
      • Table Global nicotine abuse treatment market 2016-2021 ($ million)
    • Global drugs abuse treatment market
      • Table Drugs illicitly used worldwide
      • Table Global drug abuse treatment market 2016-2021 ($ million)
  • Geographical segmentation
    • Table Global substance abuse treatment market by geography 2016 and 2021
    • Table Global substance abuse treatment market by geography 2016-2021 ($ million)
    • Substance abuse market in Americas
      • Table Market scenario in Americas
      • Table Substance abuse treatment market in Americas 2016-2021 ($ million)
    • Substance abuse market in EMEA
      • Table Market Scenario in EMEA
      • Table Substance abuse treatment market in EMEA 2016-2021 ($ million)
    • Substance abuse market in APAC
      • Table Market Scenario in APAC
      • Table Substance abuse treatment market in APAC 2016-2021 ($ million)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Various approaches in substance abuse treatment
    • Market challenges
      • Table Factors contributing to overall cost of substance abuse treatment
      • Table Reasons for poor patient compliance
  • Market trends
    • Table Rehabilitation center acquisitions in recent years
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global substance abuse treatment market 2016
      • Table Competitive factors in global substance abuse treatment market
      • Table Market penetration of vendors in global substance abuse treatment market 2016
      • Table Strategic success factors of companies in global substance abuse treatment market
  • Key vendor analysis
    • Alkermes
      • Table Alkermes: Strength assessment
      • Table Alkermes: Strategy assessment
      • Table Alkermes: Opportunity assessment
    • Allergan
      • Table Allergan: Key highlights
      • Table Allergan: Strength assessment
      • Table Allergan: Strategy assessment
      • Table Allergan: Opportunity assessment
    • GSK
      • Table GSK: Key highlights
      • Table GSK: Strength assessment
      • Table GSK: Strategy assessment
      • Table GSK: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report